Summary
Blueclinic LTD is a UK-registered company incorporated in 2017 and described as a micro business in the health sector. It operates as an online prescription forwarding service rather than a direct seller of medicines. Legal cases in the Netherlands against the operator of Dokteronline.com highlighted risks in cross-border online medicine supply, with Blueclinic mentioned in analyses as part of that model. Regulatory frameworks in both the UK and the Netherlands set clear obligations, and mixed customer reviews underline the company’s contested reputation.
Context and Scope
This account focuses on the formal company details of Blueclinic LTD, its business model, Dutch legal rulings relevant to related services, references to its role in cross-border supply, the UK and Dutch regulatory frameworks, and its reputation signals.
Exhaustive Narrative of Facts
UK company details
Blueclinic LTD is officially registered in the United Kingdom under number 10811735. It was incorporated on 9 June 2017 and is based at 20–22 Wenlock Road, London, N1 7GU. The registered activity is “Other human health activities.” It is categorized as a micro company, with turnover under £1 million and assets under £500,000. Directors have included Maarten-Vincent Peeters, appointed in December 2024, and Rory Aidan Mulvaney, who stepped down as director in the same month.
Business model
Blueclinic presents itself as an online prescription forwarding service. It states that it does not sell or supply medicines directly but connects customers who have prescriptions with affiliated pharmacies that can fulfill them.
Dutch legal rulings
In 2021, the Dutch Council of State confirmed two fines against the company behind Dokteronline.com for breaching the Dutch Medicines Act. Violations included offering prescription-only and pharmacy-only medicines without a registered pharmacist and failing to display the required European distance-selling logo. Summaries of the rulings reference several statutory articles, including Articles 61, 67a, 84, and 85.
Relationship references
Legal analysis in the Netherlands described Blueclinic LTD as registered as an official online medicines provider, facilitating the supply of medicines to Dutch consumers in cooperation with Dokteronline. This arrangement was presented as a way to work around national restrictions on remote prescribing without physical consultation.
UK regulatory framework
The UK Medicines and Healthcare products Regulatory Agency maintains a register of authorised online sellers of medicines. The General Pharmaceutical Council separately regulates and registers physical pharmacy premises. Blueclinic LTD does not appear on the publicly available MHRA register of authorised sellers.
Dutch regulatory framework
The Dutch Health and Youth Care Inspectorate is responsible for overseeing the supply of medicines and compliance with the Dutch Medicines Act. It sets out requirements for supplying unregistered medicines. Although enforcement has targeted Dokteronline’s operator, there is no evidence that Blueclinic LTD itself has been the subject of Dutch sanctions.
Reputation signals
Customer reviews linked to Blueclinic and associated domains report mixed experiences. Some users describe delays, poor communication, and unclear pricing, while others report satisfactory service. Independent technical trust analyses of related domains, such as blueclinic.nl, rate them average to good on security and reliability indicators but caution that such ratings do not assess business practices.
Practical Takeaways
- Blueclinic LTD is a formally registered UK company, established in 2017 and classed as a micro business.
- It functions as a prescription forwarding service, not a direct seller of medicines.
- Dutch authorities sanctioned Dokteronline for unlawful online medicine sales, and Blueclinic has been referenced as part of that cross-border supply structure.
- The company does not appear on the UK MHRA’s list of authorised online medicine sellers.
- Mixed customer reviews and domain trust scores highlight questions about reliability and transparency.
My Diary - Leonardo Cardillo 